How did GMAB's Q3 2023 earnings surprise impact its stock?

Genmab's (GMAB) Q3 2023 earnings report showed a significant positive surprise, with a net income growth of 181.97% and a net income of $533.69 million. Despite this positive news, the stock experienced a decline of 4.42%. This suggests that the market may have had concerns or reacted differently to the earnings report, which is worth investigating further for a comprehensive understanding.